Annual Heart Day Symposium
With generous support from the Department of Biomedical Engineering W. H. Coulter Lecture Series at FIU, we established the Miami Heart Month to coincide with the American Heart Month recognized nationally by the AHA, CDC, and NHLBI. For three consecutive Fridays in February, we invite renowned investigators to Miami for a series of seminars focused on cardiovascular research. The goal of the Heart Day Symposium is to gather cardiovascular researchers from across South Florida to learn from each other and discuss current research and lingering challenges in cardiovascular medicine.
SPRING 2022 – FRIDAY, FEBRUARY 18, 2022
Florida International University
MMC (Main) Campus
Everglades Residence Hall 141
1590 SW 111th Avenue, Miami, FL 33199
9:00 am – 4:00 pm
Donate blood at the ONE BLOOD TRUCK, Everglades Hall MPR141, lawn area 10:00 am – Networking and poster symposium featuring trainees and cardiovascular research and medicine
12:00 noon – Lunch
3:45 pm – Panel discussion on issues and opportunities in cardiovascular medicine and research
4:45 pm – Concluding Remarks
Made possible by the FIU BME
Wallace H. Coulter Foundation Lecture Series
Participants & Supporters
MEET OUR GUEST SPEAKERS
Keith March, M.D., Ph.D.
Keith March, M.D., Ph.D., FACC, serves as Director for the University of Florida (UF) Center for Regenerative Medicine; Vice Chief, Cardiology Research; and Professor in the UF Division of Cardiovascular Medicine and UF Department of Medicine.
Dr. March has dedicated his career to bringing new medical approaches to patients. His publications include more than 150 manuscripts. He was the editor of the first book dedicated to cardiovascular gene transfer. Dr. March’s research has resulted in more than 55 worldwide (20+ U.S.) patents, with others pending. He invented the Closer, a widely-utilized patented suture-mediated closure device, used to close the puncture wound in an artery following heart catheterization. This device allows a patient to “walk off the table” after a catheterization without requiring prolonged bed rest. In 1999, Abbott Vascular, an affiliate of Abbott Laboratories, acquired the company that developed this technology; and the Closer approach has been used worldwide to treat more than 8,000,000 patients. He has served as a scientific advisor to numerous pharmaceutical, biotechnology, and medical device companies.
Tarak Rambhatla, M.D.
Tarak Rambhatla, M.D., is a clinical cardiologist. He specializes in the diagnosis and treatment of complex cardiovascular disease including critical care cardiology, cardiomyopathies, valvular heart disease, arrhythmias, coronary artery disease, and heart failure. He completed his cardiology training in New York City, where under the direction of world-renowned Echocardiographer Itzhak Kronzon, he mastered the utilization of echocardiography in assessment of hemodynamics and valvular heart disease, using both transesophageal and transthoracic echo. His other interest includes heart rhythm disorders, particularly early detection and management of atrial fibrillation, an arrhythmia that leads to heart failure and strokes, and affects more than 2 million Americans. He has given lectures both nationally and internationally on this topic.
He is a published author in several renowned scientific journals, including the International Journal of Cardiology and JACC EP. He is also the lead author for the upcoming Echocardiography Companion, a Board Review Preparation Book for Clinicians. He is an active member of several professional societies, including the American College of Cardiology, American Society of Echocardiography, Cardiac Electrophysiology Society, and Society of Cardiovascular Computed Tomography.